Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases

PURPOSE: The liver is one of the most common sites for metastatic solid tumors. If the liver is the only site of metastatic disease, regional treatment options can offer the benefit of high local exposure with limited systemic toxicity, especially for patients without (further) systemic treatment op...

Descripción completa

Detalles Bibliográficos
Autores principales: van Iersel, Liselot B. J., Hoekman, Ellen J., Gelderblom, Hans, Vahrmeijer, Alexander L., van Persijn van Meerten, Els L., Tijl, Fred G. J., Hartgrink, Henk H., Kuppen, Peter J. K., Nortier, Johan W. R., Tollenaar, Rob A. E. M., van de Velde, Cornelis J. H.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467497/
https://www.ncbi.nlm.nih.gov/pubmed/18470571
http://dx.doi.org/10.1245/s10434-008-9881-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467497/
https://www.ncbi.nlm.nih.gov/pubmed/18470571
http://dx.doi.org/10.1245/s10434-008-9881-6

Ejemplares similares